Legal Representation
Attorney
Christopher N. Bolinger and Arthur Silverstein, Richard Friedman, Cynthia Arellano, Tiffany Trunko, Jennet Walker, Sudipta Rao, Stacey Hallerman, Cindy M. Zelson, Heather McDonald, Jane Ungaro, Warren Zeserman, Romy Corliss and Judy McCool.
USPTO Deadlines
Application History
29 eventsDate | Code | Type | Description |
---|---|---|---|
Dec 20, 2007 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
Dec 20, 2007 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
Aug 29, 2007 | EX5G | S | SOU EXTENSION 5 GRANTED |
Jun 7, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jun 7, 2007 | EXT5 | S | SOU EXTENSION 5 FILED |
Nov 14, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Nov 14, 2006 | EXT4 | S | SOU EXTENSION 4 FILED |
Nov 14, 2006 | EX4G | S | SOU EXTENSION 4 GRANTED |
Jun 14, 2006 | EX3G | S | SOU EXTENSION 3 GRANTED |
May 31, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
May 31, 2006 | EXT3 | S | SOU EXTENSION 3 FILED |
Dec 2, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Dec 2, 2005 | EXT2 | S | SOU EXTENSION 2 FILED |
Dec 2, 2005 | EX2G | S | SOU EXTENSION 2 GRANTED |
May 26, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
May 26, 2005 | EXT1 | S | SOU EXTENSION 1 FILED |
May 26, 2005 | EX1G | S | SOU EXTENSION 1 GRANTED |
Jan 5, 2005 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Jan 5, 2005 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Dec 14, 2004 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Sep 21, 2004 | PUBO | A | PUBLISHED FOR OPPOSITION |
Sep 1, 2004 | NPUB | O | NOTICE OF PUBLICATION |
Jul 9, 2004 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jun 28, 2004 | I | PAPER RECEIVED | |
Jun 28, 2004 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jun 28, 2004 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED |
May 28, 2004 | CNRT | F | NON-FINAL ACTION MAILED |
May 24, 2004 | DOCK | D | ASSIGNED TO EXAMINER |
Dec 9, 2003 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, preparations to lower cholesterol, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005